ZA200804027B - Neuroendocrine tumor treatment using m TOR inhibitors - Google Patents
Neuroendocrine tumor treatment using m TOR inhibitorsInfo
- Publication number
- ZA200804027B ZA200804027B ZA200804027A ZA200804027A ZA200804027B ZA 200804027 B ZA200804027 B ZA 200804027B ZA 200804027 A ZA200804027 A ZA 200804027A ZA 200804027 A ZA200804027 A ZA 200804027A ZA 200804027 B ZA200804027 B ZA 200804027B
- Authority
- ZA
- South Africa
- Prior art keywords
- tumor treatment
- neuroendocrine tumor
- tor inhibitors
- tor
- inhibitors
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0523658A GB0523658D0 (en) | 2005-11-21 | 2005-11-21 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200804027B true ZA200804027B (en) | 2009-03-25 |
Family
ID=35580407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200804027A ZA200804027B (en) | 2005-11-21 | 2008-05-12 | Neuroendocrine tumor treatment using m TOR inhibitors |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101360496B (en) |
GB (1) | GB0523658D0 (en) |
ZA (1) | ZA200804027B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110755438A (en) * | 2019-11-22 | 2020-02-07 | 昆明医科大学 | Application of levofloxacin antibiotic in preparing anti-cancer drug sensitizing drug and anti-cancer drug thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2442849A1 (en) * | 2001-04-06 | 2002-10-17 | Wyeth | Antineoplastic combinations such as rapamycin together with gemcitabine or fluorouracil |
CA2447732A1 (en) * | 2001-06-01 | 2002-12-12 | Wyeth | Antineoplastic combinations |
EP1720574A4 (en) * | 2004-02-23 | 2009-09-09 | Sugen Inc | Method of treating abnormal cell growth using c-met and-tor inhibitors |
-
2005
- 2005-11-21 GB GB0523658A patent/GB0523658D0/en not_active Ceased
-
2006
- 2006-11-20 CN CN200680051365.0A patent/CN101360496B/en not_active Ceased
-
2008
- 2008-05-12 ZA ZA200804027A patent/ZA200804027B/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB0523658D0 (en) | 2005-12-28 |
CN101360496B (en) | 2015-02-25 |
CN101360496A (en) | 2009-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL253698A0 (en) | Neuroendocrine tumor treatment using mtor inhibitors | |
ZA200805877B (en) | Pyridiazinone derivatives for tumour treatment | |
IL179398A0 (en) | Dpp-ib inhibitors | |
IL183889A0 (en) | Treatment method | |
IL188430A0 (en) | Treatment of tumors | |
IL186408A0 (en) | Combination treatment methods | |
EP1755394A4 (en) | Cancer treatment method | |
ZA200705059B (en) | Cancer treatment method | |
PT1830847E (en) | Treatment for cancer | |
IL179323A0 (en) | Cancer treatment method | |
GB2430002B (en) | Well treatment | |
IL179359A0 (en) | Cancer treatment method | |
IL184330A0 (en) | Treatment apparatus | |
EP2088862A4 (en) | Cancer treatment method | |
GB0428187D0 (en) | Cancer treatment | |
GB0421355D0 (en) | Inhibitors | |
GB0413346D0 (en) | Treating cancer | |
EP1802617A4 (en) | Cancer treatment method | |
GB0525535D0 (en) | Tumour treatment | |
GB0426141D0 (en) | Treatment | |
GB0424085D0 (en) | Well treatment | |
ZA200804027B (en) | Neuroendocrine tumor treatment using m TOR inhibitors | |
GB0421356D0 (en) | Inhibitors | |
GB0507685D0 (en) | Cancer treatment | |
GB0404675D0 (en) | Cancer treatment |